Citation: Cw. Kaplan et al., 16S ribosomal DNA terminal restriction fragment pattern analysis of bacterial communities in feces of rats fed Lactobacillus acidophilus NCFM, APPL ENVIR, 67(4), 2001, pp. 1935-1939
Citation: Me. Sanders et Tr. Klaenhammer, The scientific basis of Lactobacillus acidophilus NCFM functionality as a probiotic, J DAIRY SCI, 84(2), 2001, pp. 319-331
Authors:
Fogt, F
Urbanski, SJ
Sanders, ME
Furth, EE
Zimmerman, RL
Deren, JJ
Noffsinger, AE
Vortmeyer, AO
Hartmann, CJ
Odze, RL
Brown, CA
Citation: F. Fogt et al., Distinction between dysplasia-associated lesion or mass (DALM) and adenomain patients with ulcerative colitis, HUMAN PATH, 31(3), 2000, pp. 288-291
Authors:
Seibold, JR
Korn, JH
Simms, R
Clements, PJ
Moreland, LW
Mayes, MD
Furst, DE
Rothfield, N
Steen, V
Weisman, M
Collier, D
Wigley, FM
Merkel, PA
Csuka, ME
Hsu, V
Rocco, S
Erikson, M
Hannigan, J
Harkonen, WS
Sanders, ME
Citation: Jr. Seibold et al., Recombinant human relaxin in the treatment of scleroderma - A randomized, double-blind, placebo-controlled trial, ANN INT MED, 132(11), 2000, pp. 871
Citation: Me. Sanders et al., Detection of a variant SYT-SSX1 fusion in a case of predominantly epithelioid synovial sarcoma, MOL DIAGN, 4(1), 1999, pp. 65-70
Authors:
Rao, CV
Sanders, ME
Indranie, C
Simi, B
Reddy, BS
Citation: Cv. Rao et al., Prevention of colonic preneoplastic lesions by the probiotic Lactobacillusacidophilus NCFMTM in F344 rats, INT J ONCOL, 14(5), 1999, pp. 939-944
Citation: Me. Sanders et Jhi. 'T Veld, Bringing a probiotic-containing functional food to the market: microbiological, product, regulatory and labeling issues, ANTON LEEUW, 76(1), 1999, pp. 293-315